Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Sally Stenning"'
Autor:
Patrick Tan, Ruth Langley, Matthew Nankivell, Sally Stenning, William Allum, Alicia Okines, Massimo Rugge, Matteo Fassan, Nicola Valeri, Clare Peckitt, Richie Soong, Andrew Wotherspoon, David Cunningham, Shenli Zhang, Elizabeth Smyth
Association between genotype and toxicity Grade 3 or greater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1737d340013d7045780dacbcb63f6226
https://doi.org/10.1158/1078-0432.22461915.v1
https://doi.org/10.1158/1078-0432.22461915.v1
Autor:
Patrick Tan, Ruth Langley, Matthew Nankivell, Sally Stenning, William Allum, Alicia Okines, Massimo Rugge, Matteo Fassan, Nicola Valeri, Clare Peckitt, Richie Soong, Andrew Wotherspoon, David Cunningham, Shenli Zhang, Elizabeth Smyth
Purpose: Germline polymorphisms may affect chemotherapy efficacy and toxicity. We examined the effect of polymorphisms in drug metabolism and DNA repair genes on pathologic response rates, survival, and toxicity for patients randomized to surgery alo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fdf75ec3254aaaf2de5a69a47378b9a
https://doi.org/10.1158/1078-0432.c.6524952.v1
https://doi.org/10.1158/1078-0432.c.6524952.v1
Publikováno v:
Systematic Reviews
Background Search strategies for systematic reviews aim to identify all evidence relevant to the research question posed. Reports of methodological research can be difficult to find leading to biased results in systematic reviews of research methodol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f78c3722df45bddcd4897f9a0111e689
https://pubmed.ncbi.nlm.nih.gov/28830570
https://pubmed.ncbi.nlm.nih.gov/28830570
Autor:
Sophie D. Fosså, Peter M. Wilkinson, Neil K. Aaronson, Pat Cook, Graham M. Mead, J. Trevor Roberts, Ronald de Wit, Pieter H.M. de Mulder, Sally Stenning, Andrew Bottomley, Laurence Collette, Linda de Prijck
Publikováno v:
Journal of Clinical Oncology, 21, 6, pp. 1107-18
Journal of Clinical Oncology, 21, 1107-18
Journal of Clinical Oncology, 21, 1107-18
Purpose: To describe global quality of life (GLQL) in patients with metastatic testicular cancer (TC) treated with four different schedules of bleomycin, etoposide, and cisplatin (BEP) chemotherapy (four v three cycles given over 5 v 3 days). Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2416f82e7f7832db665c50275e732e7a
https://doi.org/10.1200/jco.2003.02.075
https://doi.org/10.1200/jco.2003.02.075
Publikováno v:
Journal of Clinical Oncology. 19:3997-3999
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2aa9bcafeba52c7a839a5d70efc7498b
https://doi.org/10.1200/jco.2001.19.19.3997
https://doi.org/10.1200/jco.2001.19.19.3997
Autor:
P. A. Cook, J. Trevor Roberts, Pieter H.M. de Mulder, Sophie D. Fosså, Graham M. Mead, Ronald de Wit, Sally Stenning, Linda de Prijck, Peter M. Wilkinson, Laurence Collette
Publikováno v:
Journal of Clinical Oncology, 19, 6, pp. 1629-40
Journal of Clinical Oncology, 19, 1629-40
Journal of Clinical Oncology, 19, 1629-40
PURPOSE: To test the equivalence of three versus four cycles of bleomycin, etoposide, and cisplatin (BEP) and of the 5-day schedule versus 3 days per cycle in good-prognosis germ cell cancer. PATIENTS AND METHODS: The study was designed as a 2 × 2 f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fce6fbb8c9f449fa1d030dea2c54f91
https://hdl.handle.net/2066/186800
https://hdl.handle.net/2066/186800
Autor:
Sally Stenning, Malcolm Mason, GM Mead, Jorge Aparicio, Hannes Steiner, Maria De Santis, Tim Oliver, Iwona Skoneczna, Christian Kratzik, Klaus Peter Dieckmann
Publikováno v:
Journal of Clinical Oncology. 24:2599-2600
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3bfaec6ddfa341d0c423a16ddbd7595
https://doi.org/10.1200/jco.2006.06.0665
https://doi.org/10.1200/jco.2006.06.0665
Autor:
Laurence S. Freedman, Sally Stenning
Publikováno v:
Controlled Clinical Trials. 9:253
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e988e987a790ad973b78c46a3e34953e
https://doi.org/10.1016/0197-2456(88)90104-3
https://doi.org/10.1016/0197-2456(88)90104-3
Autor:
Stoneham, Sara J., Hale, Juliet P., Rodriguez‐Galindo, Carlos, Dang, Ha, Olson, Thomas, Murray, Matthew, Amatruda, James F., Thornton, Claire, Arul, G. Suren, Billmire, Deborah, Krailo, Mark, Stark, Dan, Covens, Al, Hurteau, Jean, Stenning, Sally, Nicholson, James C., Gershenson, David, Frazier, A. Lindsay
Publikováno v:
Oncologist; Jul2014, Vol. 19 Issue 7, p689-692, 4p
Autor:
van Leeuwen, Marieke1, Kieffer, Jacobien M.1, Efficace, Fabio2, Fosså, Sophie D.3, Bolla, Michel4, Collette, Laurence5, Colombel, Marc6, De Giorgi, Ugo7, Holzner, Bernhard8, van de Poll-Franse, Lonneke V.1,9,10, van Poppel, Hendrik11, White, Jeff12, de Wit, Ronald13, Osanto, Susanne14, Aaronson, Neil K.1 n.aaronson@nki.nl, European Organisation for Research and Treatment of Cancer Quality of Life Group (CORPORATE AUTHOR), Genito-Urinary Cancers Group and Radiation Oncology Group (CORPORATE AUTHOR), and the NCRN Testis Clinical Studies Group (CORPORATE AUTHOR)
Publikováno v:
Health & Quality of Life Outcomes. 05/11/2017, Vol. 15, p1-14. 14p.